Table 1 The 2016–2017 routine vaccine programme in England, adapted from Public Health England (2018) [8]
Age | Disease(s) | Vaccine (trade name) | Notes, including schedule changes implemented during the study period |
 8 weeks | Diphtheria, tetanus, pertussis, polio, Haemophilus influenza type b (Hib) | DTaP/IPV/Hib (Pediacel or Infanrix IPV Hib) | Changed to Infanrix Hexa, with hepatitis B (Hep B) included in 2018 |
Pneumococcal (13 serotypes) | Pneumococcal Conjugate (PCV) (Prevenar 13) | Â | |
Meningococcal group B (MenB) | MenB (Bexsero) | Â | |
Rotavirus | Rotavirus (Rotarix) | Â | |
 12 weeks | Diphtheria, tetanus, pertussis, polio and Hib | DTaP/IPV/Hib (Pediacel or Infanrix IPV Hib) | Changed to Infanrix Hexa, with hepatitis B (Hep B) included in 2018 |
Rotavirus | Rotavirus (Rotarix) | Â | |
 16 weeks | Diphtheria, tetanus, pertussis, polio and Hib | DTaP/IPV/Hib (Pediacel or Infanrix IPV Hib) | Changed to Infanrix Hexa, with hepatitis B (Hep B) included in 2018 |
MenB | MenB (Bexsero) | Â | |
Pneumococcal (13 serotypes) | PCV (Prevenar 13) | Â | |
 1 year | Hib and MenC | Hib/MenC booster (Menitorix) |  |
Pneumococcal 13 | PCV Booster (Prevenar 13) | Â | |
Measles, mumps and rubella (MMR) | MMR (VaxPRO or Priorix) | Â | |
MenB | MenB booster (Bexsero) | Â | |
 2–6 years | Influenza (seasonal) | Live attenuated influenza vaccine (LAIV) (Fluenz Tetra) | Seasonal vaccine—excluded from this study |
 From 3 years 4 months | Diphtheria, tetanus, pertussis and polio | DTaP/IPV (Infanrix IPV or Repevax) |  |
MMR | MMR (VaxPRO or Priorix) | Â | |
 Females 12–13 years | Human papillomavirus (HPV) | HPV (two doses 6 to 24 months separated) (Gardasil) | Usually given in school—excluded from this study unless given in the GP practice |
 14 years | Tetanus, diphtheria and polio | Td/IPV (Revaxis) | Usually given in school—excluded from this study unless given in the GP practice |
Meningococcal groups A, C, W and Y | Men ACWY (Nimenix or Menveo) | Usually given in school—excluded from this study unless given in the GP practice | |
 65 years | Pneumococcal (23 serotypes) | Pneumococcal polysaccharide (PPV) (Pneumovax II) |  |
 > 65 years | Influenza (seasonal) | Inactivated influenza vaccine (strain dependent) | Seasonal vaccine—excluded from this study |
 70 years | Shingles | Shingles (Zostavax) |  |
Condition | Disease(s) | Vaccine (trade name) | Notes |
 Pregnancy | Influenza (seasonal) | Inactivated influenza vaccine (strain dependent) | Seasonal vaccine—excluded from this study |
Pertussis | DTaP/IPV (Boostrix-IPV) | From 16Â weeks gestation | |
 Various underlying medical conditions | Meningococcal Pneumococcal Influenza Hepatitis A and B HiB | Various | Patients with a wide range of medical conditions (asplenia, diabetes, respiratory, neurological) are eligible for a range of vaccines |